Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.260
-0.045 (-3.45%)
At close: Sep 30, 2026, 4:00 PM EDT
1.280
+0.020 (1.59%)
After-hours: Sep 30, 2026, 7:55 PM EDT
Acurx Pharmaceuticals Stock Forecast
ACXP's stock price has decreased by -70.56% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, Acurx Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $17. The average 1-year stock price forecast is 1,249.21% higher than the current stock price, while the lowest is $10 (+693.65%) and the highest is $31 (+2,360.32%).
Price Target: $17 (+1,249.21%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Acurx Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Mar '26 | May '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $10 | Buy | Reiterates | $10 | +693.65% | Sep 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $31 | Buy | Reiterates | $31 | +2,360.32% | Sep 29, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $10 | Buy | Maintains | $10 | +693.65% | Aug 17, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.93
from -5.32
EPS Next Year
-1.75
from -1.93
EPS and Forward PE are based on non-GAAP adjusted numbers.